Meghan Hosely

Marketing Content Manager, Advarra

Meghan Hosely is the Marketing Content Manager at Advarra, creating content across the business. In her role, Hosely provides educational content for Advarra’s website, such as blogs, eBooks, white papers, and more. Hosely has been with Advarra since 2019, working with subject matter experts to produce relevant and timely content for the Advarra website.

Latest Posts by Meghan Hosely

Blog

Patient Recruitment from a Site Perspective: Technology Meeting Today’s Challenges

Effective participant recruitment is crucial to a successful clinical trial, and as trials become more...

Read More...
FDA Guidance Offers New Flexibility and Efficiency to Biotechs Developing Cellular or Gene Therapy Products
Blog

FDA Guidance Offers New Flexibility to Biotechs in Cell and Gene Therapy

The Food and Drug Administration (FDA) recently released new guidance regarding cellular and gene therapy...

Read More...
Blog

How Single IRB Works in Practice: Challenges and Efficiencies

The single institutional review board (sIRB) model is gaining popularity due to NIH and OHRP...

Read More...
Blog

Sickle Cell Disease: The Importance of Amplifying Patient Voices

Having a one in four chance of developing sickle cell disease (SCD) is uniquely, and...

Read More...
Blog

Advancing Diversity, Equity, and Inclusion in Clinical Research: A Path Towards Health Equity

  In clinical research, diversity, equity, and inclusion (DEI) is becoming increasingly recognized as essential...

Read More...
Blog

Regulatory Trends in Cell and Gene Therapies

As cell and gene therapy advances, the FDA is shaping regulatory trends to streamline approvals,...

Read More...
Blog

Understanding FDA’s Draft Guidance on Ethical Considerations for Involving Children in Clinical Trials

In 2016, the Food and Drug Administration (FDA) approved Spinraza (nusinersen). It was the first...

Read More...
Blog

Patient-centric Clinical Trials: Evolving Strategies for Engagement and Retention

  In the ever-evolving world of clinical research, patient engagement has become a critical focus...

Read More...
21 cfr part 11 compliant software image with a lock
Blog

Beginner’s Guide to 21 CFR Part 11 Compliance

Ensuring 21 CFR Part 11 compliance in research software protects data integrity, security, and audit...

Read More...
An Evolving Regulatory Environment for Rare and Orphan Diseases
Blog

An Evolving Regulatory Environment for Rare and Orphan Diseases

Rare diseases affect fewer than 200,000 people each, totaling around 30 million in the U.S....

Read More...
Blog

5 Questions to Ask Your Sponsor for DCT Implementation

The pandemic proved decentralized clinical trials (DCTs) can reduce patient burden while delivering quality data...

Read More...
ich q12 guidance
Blog

Regulatory Considerations for Pharmaceutical Product Lifecycle Management

As a pharmaceutical product makes its way through the lifecycle, there are often Food and...

Read More...
Scroll to Top